Clinical Trial

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Study acronym: RANGER®
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2012-02-02; most recent amendment 2026-01-23.
Status change: Recruiting → Active, Not Recruiting 2026-01-23
Trial Details
NCT Number NCT01526681
Lead Sponsor Axogen Corporation
Conditions Peripheral Nerve Injuries
Enrollment 3,126 participants
Start Date 2008-11
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-26